Averi Kit
Product Images NDC 75854-604

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Averi (NDC 75854-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avion Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Averi 1)

Chemical structure diagram showing desogestrel (C22H30O) and ethinyl estradiol (C20H24O2) molecules, the active ingredients in the product AVERI. Each chemical structure is labeled with its respective molecular formula.*

FDA Label Image

Averi 3-cycle Carton (Averi 10)

Packaging label for AVERI, a kit containing desogestrel and ethinyl estradiol tablets, USP 0.15 mg/0.03 mg and ferrous bisglycinate tablets 36.5 mg. The label indicates a 28-day regimen with 3 blister packs of 28 tablets each. It includes dosage and safety information, the Avion Pharmaceuticals, LLC labeler information, and barcodes for product identification.*

FDA Label Image

Figure 1 (Averi 2)

A bar chart displaying circulatory disease mortality rates per 100,000 women-years, categorized by age groups (15-24, 25-34, 35-44, 45+), smoking status, and oral contraceptive use. Four groups are compared: ever-users (non-smokers and smokers) and controls (non-smokers and smokers), with mortality rates shown on the vertical axis.*

FDA Label Image

Table 2 (Averi 3)

A data table titled 'Annual Number of Birth-Related or Method-Related Deaths Associated with Control of Fertility per 100,000 Nonsterile Women, by Fertility Control Method According to Age.' It compares mortality rates across different fertility control methods (no fertility control, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, periodic abstinence) across age groups from 15 to 44 years.*

FDA Label Image

Figure 2 (Averi 4)

A forest plot titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' displays effect estimates (odds ratios or relative risks) from multiple cohort studies spanning 2002 to 2017. The plot compares breast cancer risk for females with current or past combined oral contraceptive (COC) use against those who never used COCs, with confidence intervals shown for each study's effect estimate.*

FDA Label Image

Avion Logo (Averi 5)

FDA Label Image

Ifu Image 1 (Averi 6)

The image shows an AVERI kit blister card for oral contraceptive tablets by Avion Pharmaceuticals, LLC. The card is organized by day of the week (Sunday to Saturday) and week number (1 to 4) with orange and blue tablet placeholders indicating different tablet types. The card instructs taking active orange tablets in the first three weeks and inactive blue tablets containing inactive ingredients in week four. The package contains 28 tablets in total.*

FDA Label Image

Ifu Image 2 (Averi 7)

Illustration showing a hand peeling back the protective overlay of an AVERI desogestrel and ethinyl estradiol oral contraceptive kit. The visible blister pack is organized by days of the week with color-coded pills (orange and blue) arranged in a sequence. The image serves as an instructional diagram for use of the AVERI birth control pill kit by Avion Pharmaceuticals, LLC.*

FDA Label Image

Avion Logo (Averi 8)

FDA Label Image

Averi 1-cycle Carton (Averi 9)

Box packaging label for Averi, a 28-day regimen kit containing 28 tablets. The product contains desogestrel 0.15 mg, ethinyl estradiol 0.03 mg, and ferrous bisglycinate 36.5 mg in tablet form. Labeler is Avion Pharmaceuticals, LLC. The carton includes warnings that the product is an oral contraceptive and does not protect against HIV or other sexually transmitted diseases. The design features the name Averi with a stylized floral logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.